Effects of Metreleptin in Type 1 Diabetes Mellitus

This study is currently recruiting participants.
Verified June 2013 by University of Texas Southwestern Medical Center
Sponsor:
Collaborators:
Juvenile Diabetes Research Foundation
Amylin Pharmaceuticals, LLC.
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01268644
First received: December 29, 2010
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2014
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)